ARTICLE | Distillery Therapeutics
Infectious disease
February 13, 2019 1:31 PM UTC
In vitro and mosquito studies identified a quinazoline-based agonist of A. aegypti NPYLR7 that could help prevent A. aegypti mosquito bites and associated infections. In vitro screening of a compound ...
BCIQ Company Profiles
BCIQ Target Profiles